Divi’s Lab Shares Jump 5% Due to the Company’s Impressive Q3 Results: Get More Details
The pharmaceutical business Divi’s Laboratories announced a 64.5% YoY profit growth in Q3 FY25, powered by Custom Synthesis, which caused the share price to rise by 5%. Jefferies admits that revenue aligns with projections but worries about product concentration still exist. Divi’s Laboratories Q3 Results: A day after Divi’s Laboratories released its third-quarter (Q3) earnings […]
Divi’s Lab Shares Jump 5% Due to the Company’s Impressive Q3 Results: Get More Details Read More »